USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: C2N DIAGNOSTICS, LLC
City: SAINT LOUIS
State: MO
Zip+4: 63108-3213
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $295,025.00 2
SBIR Phase II $814,440.00 1

Award List:

Measuring metabolism of C-terminal fragments of amyloid beta in the human central

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Tim West
Award Amount: $133,098.00
Abstract:
DESCRIPTION (provided by applicant): This grant will seek to develop a methodology that will allow us to test whether a promising new class of drugs for Alzheimer's disease is having the desired effect in the human brain. This methodology will allow pharma ceutical companies to make informed… More

Measuring metabolism of C-terminal fragments of amyloid beta in the human central

Award Year / Program / Phase: 2011 / SBIR / Phase II
Agency: HHS
Principal Investigator: Tim West – 314-633-1886
Award Amount: $814,440.00
Abstract:
DESCRIPTION (provided by applicant): This grant will seek to develop a methodology that will allow us to test whether a promising new class of drugs for Alzheimer's disease is having the desired effect in the human brain. This methodology will allow pharmaceutical companies to make informed… More

Development of novel assays for measuring concentration and metabolism of Tau in

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Tim West – 314-633-1886
Award Amount: $161,927.00
Abstract:
DESCRIPTION (provided by applicant): Recently, Drs. Randall Bateman and David Holtzman at the Washington University School of Medicine developed a novel stable isotope labeling kinetics (SILK) methodology for measuring the metabolism of amyloid beta (AB) in the human central nervous system (CNS).… More